The invention relates to a large scale process for the in vitro production of a cell culture of pomegranate cells, to a product prepared from such cells and to a composition comprising a complex of pholyphenols, including punicalagin, 1,2,3,4,6-pentagalloyl glucose (PGG) or both.

The present invention describes a method for completely extracting the alkaloid fraction (montanine) of Rhodophiala bifida (Herb.) Traub from bulbs of Rhodophiala bifida. The present invention further describes a method for treating inflammation using pharmaceutical compositions containing the alkaloid fraction of Rhodophiala bifida as the active ingredient. The present invention therefore comprises an extraction method that is faster than other extraction methods described in the literature for the alkaloid fraction of Rhodophiala bifida, dispensing with numerous changes of solvent in order to strain the plant, and the use thereof as an anti-inflammatory. The present invention is further characterised by the development of an anti-inflammatory medicinal drug for treating and preventing diseases involving inflammation and/or the local increase in the number of fibroblasts as its etiopathogenesis, such as: rheumatoid arthritis, ulcerative colitis, sepsis, acute pulmonary disease, inflammatory infections, in particular inflammatory and fibrosing diseases related to the lungs and kidneys, osteoporosis, Castleman disease, psoriatic arthritis, juvenile chronic arthritis and other non-specific inflammatory joint diseases.

The present invention describes a method for completely extracting the alkaloid fraction (montanine) of Rhodophiala bifida (Herb.) Traub from bulbs of Rhodophiala bifida. The present invention further describes a method for treating inflammation using pharmaceutical compositions containing the alkaloid fraction of Rhodophiala bifida as the active ingredient. The present invention therefore comprises an extraction method that is faster than other extraction methods described in the literature for the alkaloid fraction of Rhodophiala bifida, dispensing with numerous changes of solvent in order to strain the plant, and the use thereof as an anti-inflammatory. The present invention is further characterised by the development of an anti-inflammatory medicinal drug for treating and preventing diseases involving inflammation and/or the local increase in the number of fibroblasts as its etiopathogenesis, such as: rheumatoid arthritis, ulcerative colitis, sepsis, acute pulmonary disease, inflammatory infections, in particular inflammatory and fibrosing diseases related to the lungs and kidneys, osteoporosis, Castleman disease, psoriatic arthritis, juvenile chronic arthritis and other non-specific inflammatory joint diseases.

The present invention pertains generally toward an easier and more efficient way to burn Palo Santo wood for aromatherapy, and more particularly toward a self-lighting match stick made of Palo Santo wood. In the present invention, the wood of Palo Santo is turned into match stick by covering the small sticks of Palo Santo with paraffin wax and match head solution. The present invention enables easy ignition of the Palo Santo wood by the user for aromatherapy and makes the process hassle free.

The present invention pertains generally toward an easier and more efficient way to burn Palo Santo wood for aromatherapy, and more particularly toward a self-lighting match stick made of Palo Santo wood. In the present invention, the wood of Palo Santo is turned into match stick by covering the small sticks of Palo Santo with paraffin wax and match head solution. The present invention enables easy ignition of the Palo Santo wood by the user for aromatherapy and makes the process hassle free.

A synthetic composition comprising a carbohydrate component, a fat component and a protein component, wherein the carbohydrate component comprises lacto-N-fucopentaose III (LNFP III) and sialyllacto-N-tetraose a (LSTa), preferably wherein the weight ratio between LNFP III and LSTa is between 1:100 and 100:1.

A synthetic composition comprising a carbohydrate component, a fat component and a protein component, wherein the carbohydrate component comprises lacto-N-fucopentaose III (LNFP III) and sialyllacto-N-tetraose a (LSTa), preferably wherein the weight ratio between LNFP III and LSTa is between 1:100 and 100:1.

Disclosed is a method of treating skin with a composition comprising an extract from Magnolia officinalis.

Disclosed is a method of treating skin with a composition comprising an extract from Magnolia officinalis.

The invention is a process of extracting 9-THC from cannabis, the method comprising, gathering a quantity of plant parts, shredding the quantity of plant parts into a particulate matter, heating the particulate matter at a temperature, wherein the particulate undergoes a decarboxylation process converting a quantity of the THCA-A within the particulate matter to a quantity of 9-THC, combining the decarboxylated particulate matter with a quantity of a predetermined liquid within a sealed pressurized container, wherein the pressure ranges from 10 to 15 PSI for a predetermined time period, wherein the quantity of the 9-THC is extracted from the decarboxylated particulate matter and the quantity of 9-THC is chemically bonded with the liquid, and a 9-THC liquid is formed, sifting the particulate matter from the 9-THC liquid, and cooling the 9-THC.